388 related articles for article (PubMed ID: 27072221)
41. The angiogenic switch for vascular endothelial growth factor-A and cyclooxygenase-2 in prostate carcinoma: correlation with microvessel density, androgen receptor content and Gleason grade.
Gyftopoulos K; Vourda K; Sakellaropoulos G; Perimenis P; Athanasopoulos A; Papadaki E
Urol Int; 2011; 87(4):464-9. PubMed ID: 21912077
[TBL] [Abstract][Full Text] [Related]
42. Precursor of prostate-specific antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 90 cases.
Hull D; Ma J; Singh H; Hossain D; Qian J; Bostwick DG
BJU Int; 2009 Oct; 104(7):915-8. PubMed ID: 19388995
[TBL] [Abstract][Full Text] [Related]
43. Decreased annexin I expression in prostatic adenocarcinoma and in high-grade prostatic intraepithelial neoplasia.
Patton KT; Chen HM; Joseph L; Yang XJ
Histopathology; 2005 Dec; 47(6):597-601. PubMed ID: 16324197
[TBL] [Abstract][Full Text] [Related]
44. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
Zhigang Z; Wenlv S
Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669
[TBL] [Abstract][Full Text] [Related]
45. Production of serum-free and total prostate-specific antigen due to prostatic intraepithelial neoplasia.
Minardi D; Galosi AB; Dell'Atti L; Hanitzsch H; Mario P; Muzzonigro G
Scand J Urol Nephrol; 2002; 36(5):323-9. PubMed ID: 12487735
[TBL] [Abstract][Full Text] [Related]
46. CIP2A expression in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue mıcroarray study.
Celikden SG; Baspinar S; Ozturk SA; Karaibrahimoglu A
Malays J Pathol; 2020 Aug; 42(2):227-236. PubMed ID: 32860375
[TBL] [Abstract][Full Text] [Related]
47. Golgi Phosphoprotein-3 and Y-Box-Binding Protein-1 Are Novel Markers Correlating With Poor Prognosis in Prostate Cancer.
Abd El-Maqsoud NM; Osman NA; Abd El-Hamid AM; Fath El-Bab TK; Galal EM
Clin Genitourin Cancer; 2016 Apr; 14(2):e143-52. PubMed ID: 26794392
[TBL] [Abstract][Full Text] [Related]
48. Elevated expression of cancer-associated proliferating cell nuclear antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer.
Wang X; Hickey RJ; Malkas LH; Koch MO; Li L; Zhang S; Sandusky GE; Grignon DJ; Eble JN; Cheng L
Prostate; 2011 May; 71(7):748-54. PubMed ID: 21031434
[TBL] [Abstract][Full Text] [Related]
49. Transforming growth factor-beta expression in prostate neoplasia.
Cardillo MR; Petrangeli E; Perracchio L; Salvatori L; Ravenna L; Di Silverio F
Anal Quant Cytol Histol; 2000 Feb; 22(1):1-10. PubMed ID: 10696454
[TBL] [Abstract][Full Text] [Related]
50. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
[TBL] [Abstract][Full Text] [Related]
51. Decreased retinoid X receptor-alpha protein expression in basal cells occurs in the early stage of human prostate cancer development.
Mao GE; Reuter VE; Cordon-Cardo C; Dalbagni G; Scher HI; DeKernion JB; Zhang ZF; Rao J
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):383-90. PubMed ID: 15006913
[TBL] [Abstract][Full Text] [Related]
52. The extent and zonal location of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: relationship with carcinoma in radical prostatectomy specimens.
Qian J; Bostwick DG
Pathol Res Pract; 1995 Sep; 191(9):860-7. PubMed ID: 8606866
[TBL] [Abstract][Full Text] [Related]
53. Overexpression of NSAID-activated gene product in prostate cancer.
Iczkowski KA; Pantazis CG
Int J Surg Pathol; 2003 Jul; 11(3):159-66. PubMed ID: 12894347
[TBL] [Abstract][Full Text] [Related]
54. DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer.
Padmanabhan V; Callas P; Philips G; Trainer TD; Beatty BG
J Clin Pathol; 2004 Oct; 57(10):1057-62. PubMed ID: 15452160
[TBL] [Abstract][Full Text] [Related]
55. Fas and Fas ligand expression is elevated in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
Jiang J; Ulbright TM; Zhang S; Eckert GJ; Kao C; Gardner TA; Koch MO; Eble JN; Cheng L
Cancer; 2002 Jul; 95(2):296-300. PubMed ID: 12124829
[TBL] [Abstract][Full Text] [Related]
56. Differential up-regulation of erythropoietin and its receptor in benign and malignant prostatic tissue.
Xu C; Zhou T; He M; Sun Y
Urol Oncol; 2010; 28(3):314-9. PubMed ID: 19070519
[TBL] [Abstract][Full Text] [Related]
57. Expression of androgen and estrogen signaling components and stem cell markers to predict cancer progression and cancer-specific survival in patients with metastatic prostate cancer.
Fujimura T; Takahashi S; Urano T; Takayama K; Sugihara T; Obinata D; Yamada Y; Kumagai J; Kume H; Ouchi Y; Inoue S; Homma Y
Clin Cancer Res; 2014 Sep; 20(17):4625-35. PubMed ID: 24987058
[TBL] [Abstract][Full Text] [Related]
58. Immunohistochemical characterization of canine prostatic intraepithelial neoplasia.
Matsuzaki P; Cogliati B; Sanches DS; Chaible LM; Kimura KC; Silva TC; Real-Lima MA; Hernandez-Blazquez FJ; Laufer-Amorim R; Dagli ML
J Comp Pathol; 2010 Jan; 142(1):84-8. PubMed ID: 19643431
[TBL] [Abstract][Full Text] [Related]
59. The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer.
Chatterjee B
Mol Cell Biochem; 2003 Nov; 253(1-2):89-101. PubMed ID: 14619959
[TBL] [Abstract][Full Text] [Related]
60. Biologic markers in prostatic intraepithelial neoplasia: immunohistochemical and cytogenetic analyses.
Tsuji M; Kanda K; Murakami Y; Kurokawa Y; Kanayama H; Sano T; Kagawa S
J Med Invest; 1999 Feb; 46(1-2):35-41. PubMed ID: 10408155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
